Current role
Biotechnology · Healthcare
Board Member, CEO, Chairman
2024-07-15–present
Richard J. Barry
Board Member
Filana Therapeutics, Inc. (FLNA)Chairman
Filana Therapeutics, Inc. (FLNA)Equibles does not estimate personal net worth.
Get an email with a short summary when Filana Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get FLNA alertsAbout Richard J. Barry
Richard J. Barry is recorded as Chairman at Filana Therapeutics, Inc. (FLNA) since July 15, 2024 and Board Member and CEO at Filana Therapeutics, Inc. (FLNA). The newest filing on record that lists Richard J. Barry as Board Member and CEO at Filana Therapeutics, Inc. (FLNA) is dated April 28, 2026. Filana Therapeutics, Inc. reported in an 8-K filed June 15, 2026 that Richard J. Barry was appointed Director, effective June 11, 2026. Filana Therapeutics, Inc. reported in an 8-K filed July 17, 2024 that Richard J. Barry was appointed Executive Chairman, effective July 15, 2024. The proxy statement of Filana Therapeutics, Inc. reports total compensation of $1,520,035 for Richard J. Barry in fiscal 2025, including a base salary of $675,000. Disclosed compensation is on record for 3 fiscal years. Filana Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Filana Therapeutics, Inc. includes Richard (Rick) Barry (CEO), Claude Nicaise (Chairman), Claude Nicaise, M.D. (Chairman and Board Member) and 7 others.
“Three (3) nominees for election or re-election to the Board of Directors were elected to serve for a three-year term, and until their successors are duly elected and qualified, based upon the following votes:”
“On July 15, 2024, Richard J. Barry, an independent director and currently the Chair of the Company's Audit and Nominating & Governance Committees, was appointed by the Board as its Executive Chairman.”
Affiliation history
-
Current
2024-07-15–present
-
Current
Start not stated–present
Last confirmed April 28, 2026
-
Current
Start not stated–present
Last confirmed April 28, 2026
Company network
Leadership on record at Filana Therapeutics, Inc.
- Richard (Rick) Barry CEO
- Claude Nicaise Chairman
- Claude Nicaise, M.D. Chairman, Board Member
- Eric J. Schoen CFO
- R. Christopher Cook COO, General Counsel
- Dawn C. Bir Board Member
- Dawn Carter Bir Board Member
- Dr. Claude Nicaise Board Member
- Jill M. Quigley Board Member
- Michael J. O'Donnell Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Filana Therapeutics, Inc. (FLNA) | President and Chief Executive Officer | $675,000 | $1,520,035 |
| 2024 | Filana Therapeutics, Inc. (FLNA) | President and Chief Executive Officer | $309,375 | $16,729,425 |
| 2023 | Filana Therapeutics, Inc. (FLNA) | President and Chief Executive Officer | — | $546,155 |